Proteros: Proteros expands oncology collaboration with AstraZeneca

This multi-year deal builds on the ongoing collaboration with AstraZeneca announced in June last year, to include the development of small molecule inhibitors targeting a second cancer-related epigenetic The post Proteros expands oncology collaboration with AstraZeneca appeared first on Pharmaceutical Business review.